Publications by authors named "Jason Valent"

Claim this Profile
R
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey.
Hossam M Ali, Zainab Yusufali Motiwala, Yara Shatnawi, Jack Khouri, Faiz Anwer, Jason Valent

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.
Rakesh Popat, Meral Beksac, Meletios A Dimopoulos, Moshe E Gatt, Francesca Gay, Jason Valent

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists.
Ali Mushtaq, Asfand Yar Cheema, Hossam M Ali, Yara Shatnawi, Omer Ashruf, Jason Valent

Blood Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes.
Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi, Jason Valent

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis.
David Kaplan, Eric Christian, Jason Valent, Faiz Anwer, Sandra Mazzoni

J Cell Mol Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first case of Teclistamab interference with serum electrophoresis and immunofixation.
Kamran Kadkhoda, Beth Faiman, Jason Valent, Samer Albahra, Nicole Boyert

Clin Chem Lab Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate Correlation.
David Kaplan, Hillard M Lazarus, Jason Valent, Faiz Anwer, Sandra Mazzoni

J Cell Mol Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Cardiac Lymphoma Masquerading as a Pericardial Mass: Imaging, 3D Printing, and Surgical Management.
Joseph Hajj, Serge C Harb, Ryan S Klatte, Sarah L Ondrejka, Jason Valent

JACC Case Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center.
Danai Dima, Utkarsh Goel, Fauzia Ullah, Beth Faiman, Diana Basali, Jason Valent

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Jason Valent

J Natl Compr Canc Netw· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first case of Teclistamab interference with serum electrophoresis and immunofixation.
Kamran Kadkhoda, Beth Faiman, Jason Valent, Samer Albahra, Nicole Boyert

Clin Chem Lab Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study.
Majid Jaberi-Douraki, Xuan Xu, Danai Dima, Sikander Ailawadhi, Faiz Anwer, Jason Valent

Blood Cancer J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.
Danai Dima, Michael Hughes, Mark Orland, Fauzia Ullah, Utkarsh Goel, Jason Valent

Amyloid· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in time to treatment with oral antimyeloma medications.
Hamlet Gasoyan, Faiz Anwer, Jeffrey D Kovach, Nicholas J Casacchia, Ming Wang, Jason Valent

Blood Cancer J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
Danai Dima, Utkarsh Goel, Aishwarya Sannareddy, Nnaemeka Ibeh, Fauzia Ullah, Jason Valent

Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Novel Targeted Therapeutic Strategies in Multiple Myeloma.
Cindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, Aishwarya Sannareddy, Farhan Khalid, Jason Valent

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of early palliative care integration on patients with newly diagnosed multiple myeloma.
Renato V Samala, Daniel P Nurse, Xiaoying Chen, Wei Wei, Jasmine J Crook, Jason Valent

Support Care Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities.
Hamlet Gasoyan, Faiz Anwer, Nicholas J Casacchia, Jeffrey D Kovach, Jason Valent

JCO Oncol Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma.
James A Davis, Danai Dima, Nausheen Ahmed, Shaun DeJarnette, Joseph McGuirk, Jason Valent

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience.
Danai Dima, James A Davis, Nausheen Ahmed, Xuefei Jia, Aishwarya Sannareddy, Jason Valent

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Jason Valent

J Natl Compr Canc Netw· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Jason Valent

J Natl Compr Canc Netw· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab monotherapy for relapsed POEMS syndrome.
Danai Dima, Jason Valent, Jack Khouri

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma.
Danai Dima, Mark Orland, Fauzia Ullah, Faiz Anwer, Sandra Mazzoni, Jason Valent

Clin Lymphoma Myeloma Leuk· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice.
Danai Dima, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman, Jason Valent

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis